139 related articles for article (PubMed ID: 10334382)
1. Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.
Viscomi GC; Antonelli G; Bruno C; Scapol L; Malavasi F; Funaro A; Simeoni E; Pestka S; De Pisa F; Dianzani F
J Interferon Cytokine Res; 1999 Apr; 19(4):319-26. PubMed ID: 10334382
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
Overall ML; Hertzog PJ
Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
[TBL] [Abstract][Full Text] [Related]
3. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
Karayianni-Vasconcelos G; Borecký L; Kontsek P
Vet Immunol Immunopathol; 1993 Oct; 38(3-4):359-65. PubMed ID: 7507275
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
Exley T; Parti S; Barwick S; Meager A
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
[TBL] [Abstract][Full Text] [Related]
5. Distinct effect of pH 2 on a common antigenic structure found in human interferons-alpha 1 and -alpha 2 in the region 30-35.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I; Krchnák V
J Interferon Res; 1991 Dec; 11(6):327-32. PubMed ID: 1724779
[TBL] [Abstract][Full Text] [Related]
6. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
7. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
Adolf GR
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions in loop BC and helix C affect antigenic properties of helix D in hybrid IFN-alpha21a/alpha2c molecules.
Schmeisser H; Hu R; Kontsek P; Bekisz J; Zoon K
J Interferon Cytokine Res; 2002 Apr; 22(4):463-72. PubMed ID: 12034029
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of four monoclonal antibodies specific for human interferon-alpha-1 and -alpha-2.
Noll F; Handschack W; Eichmann E; Gaestel M; Schneider F; Kuhl R; Löster K
Biomed Biochim Acta; 1989; 48(1):165-76. PubMed ID: 2775248
[TBL] [Abstract][Full Text] [Related]
11. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
12. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes.
Brand CM; Leadbeater L; Bellati G; Marotta F; Ideo G
J Interferon Res; 1993 Apr; 13(2):121-5. PubMed ID: 7685368
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha.
Wagner B; Hillegas JM; Flaminio MJ; Wattrang E
Vet Immunol Immunopathol; 2008 Oct; 125(3-4):315-25. PubMed ID: 18586327
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN.
Adolf GR
Virology; 1990 Apr; 175(2):410-7. PubMed ID: 1691561
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody to human beta interferon: characterization and application.
Sugi M; Kato H; Fujimoto M; Utsumi J; Hosoi K; Shimizu H; Kobayashi S
Hybridoma; 1987 Jun; 6(3):313-20. PubMed ID: 3596615
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
Antonelli G; Currenti M; Turriziani O; Dianzani F
J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
[TBL] [Abstract][Full Text] [Related]
17. A scFv antibody fragment as a therapeutic candidate to neutralize a broad diversity of human IFN-alpha subtypes.
Depetris M; Casalis P; Kratje R; Etcheverrigaray M; Oggero M
J Immunol Methods; 2008 May; 334(1-2):104-13. PubMed ID: 18394641
[TBL] [Abstract][Full Text] [Related]
18. Are the acid-labile interferon alpha and interferon omega-1 identical?
Kontsek P; Borecký L; Novák M
Virology; 1991 Mar; 181(1):416-8. PubMed ID: 1994590
[TBL] [Abstract][Full Text] [Related]
19. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
Kandefer-Szerszeń M; Lundgren E
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
[TBL] [Abstract][Full Text] [Related]
20. Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors.
Oberg K; Alm GV
J Interferon Res; 1989 Sep; 9 Suppl 1():S45-9. PubMed ID: 2809277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]